People infected with the human immunodeficiency virus (HIV) are 29 times more likely to develop tuberculosis than those who do not have HIV (1) . Globally, the incidence of tuberculosis in people living with HIV (PLH) is 105.2 per 100 000 population, and in the Andean region of Latin America it is 118.4 per 100 000 population (2) . In contrast, the worldwide incidence of tuberculosis in people without HIV is 98.7 per 100 000 population (2) , while in the Andean region of Latin America it is 117.9 per 100 000 population. Furthermore, PLH who do not receive antiretroviral therapy (ARVT) are at nine times greater risk of contracting tuberculosis than patients who do receive treatment (2) . The difference is 15 times greater in individuals with CD4 counts of less than 200 cells/mL (2) , so all AIDS patients, especially those with CD4 counts below 200, need to receive prophylaxis with isoniazid, as recommended in various management guidelines (3) (4) (5) .
In 2013, there were 1.1 million people with tuberculosis/HIV (TB/HIV) coinfection in the world (1) . Deaths from tuberculosis in PLH dropped from 540 000 in 2004 to 360 000 in 2013 (6) . However, tuberculosis remains the leading cause of death in PLH around the globe (6) .
In Peru, 1,094 cases of TB/HIV coinfection (7) were reported in 2014-an overall TB/HIV coinfection rate of around 3% (8) . The tuberculosis and HIV epidemics also have a shared epidemiological distribution (8) . Programmatic data indicate that HIV and tuberculosis are concentrated mainly in urban areas along the coast and in the jungle region, and affect in particular men in the economically active population (7, 9) . Accordingly, the proportion of TB/HIV coinfection is higher in the Loreto (6.4%), Callao (6.3%), and Northern Lima (5%) regions (8) .
To reduce the problem of TB/HIV coinfection, since 2004, the World Health Organization (WHO) (10) and other international organizations (11) have recommended implementing collaborative activities on TB/HIV. The WHO recommendations focus on implementing (or strengthening) integrated services for TB/HIV coinfection, reducing the TB/ HIV disease burden, and providing early ARVT (10) . As a result, gains have been made around the globe, with access to ARVT for patients with TB/HIV coinfection rising from 47% in 2012 to 65% in 2013 (6) . In Latin America, ARVT coverage was 76%; however, in the countries of this region, collaboration between tuberculosis and HIV programs has been hindered by the lack of joint national policies and the absence of integration activities at the operational level (12) .
The Ministry of Health of Peru, through the national health strategies for tuberculosis and HIV/AIDS, is tasked with preventing and controlling these health problems. The National Tuberculosis Standard (13) and National HIV Standard (14) outline what interventions should be implemented for each of these diseases. However, reports show low coverage in the coinfection indicators, which suggests difficulties in implementing and coordinating care for patients with TB/HIV coinfection by the two programs (which are called "strategies" in Peru).
One of the main difficulties in caring for patients with TB/HIV coinfection is that care is provided separately for tuberculosis and HIV. Furthermore, most patients with TB/HIV coinfection are treated for tuberculosis in a primary care facility, but receive ARVT in another facility, generally at the secondary or tertiary level. There is not a detailed understanding of which elements prevent the tuberculosis and HIV health strategy teams from coordinating actions to improve care for patients with TB/ HIV coinfection.
The objective of this research was to identify programmatic barriers to comprehensive care of patients with TB/ HIV coinfection. Information was gathered from services that provide care to tuberculosis and HIV patients, to identify any programmatic gaps in TB/HIV coinfection care. That information serves as input for preparing and implementing a joint national policy addressing the TB/HIV problem.
MATERIALS AND METHODS
This study is part of a new initiative: "Improving Program Implementation through Embedded Research (iPIER)", developed by the Alliance for Health Policy and Systems Research (AHPSR), in collaboration with the Pan American Health Organization (PAHO). The iPIER model makes program implementers key agents for research, to understand barriers in health systems that obstruct implementation as well as to identify solutions to these barriers. Embedded research on program implementation supports the effectiveness of existing processes and effective health policies through the utilization of research conducted as a part of the implementation process ( Figure 1) . A detailed description of implementation of the research methodology can be found in the iPIER concept paper on barriers to timely access to comprehensive care for people affected by TB/HIV coinfection in Peru.
A mixed-method study was conducted. It consisted of a qualitative component to identify barriers in caring for patients with TB/HIV coinfection, and a quantitative component to identify programmatic Implementation strategy -Analyze access barriers to diagnosis and management of coinfected patients -Address the training needs of TB and HIV health teams at the intervention sites -Standardize programmatic information at the national, regional, and local levels -Hold workshop to review barriers and build consensus for coordinating operational activities among the different levels of care -Hold coordination/management meetings between the two strategies -Devise a joint work plan Changes in the health policy or program -Preparation of a single standard of care for patients with TB/HIV coinfection -Consensus-based programmatic and operational information at the national, regional, and local levels (continuing training, screening, treatment, information system, etc.) -Greater interaction between the TB and HIV programs -Preparation of an intervention plan gaps. The study was conducted in Lima and Iquitos, two cities with high incidence of tuberculosis and HIV (8) . Seven health facilities in the district of San Juan de Lurigancho (Lima) and three districts in Iquitos were selected (Figure 2 ), because they had the greatest number of tuberculosis or HIV patients. The characteristics of the facilities are described in Table 1 .
The qualitative component was conducted via in-depth interviews with key actors in the care process. Health facilities' tuberculosis and HIV strategy coordinators, physicians, nurses, obstetricians and people with TB/HIV coinfection were selected. Professionals on the technical teams for the health strategies at the national level were also interviewed. A semi-structured questionnaire was administered by an interviewer, differentiated for health providers and patients. All the interviews were audio recorded, then transcribed. The analysis used an iterative process of reading the transcriptions, selecting subjects, and coding, using the ATLAS.ti version 7.2 ® software.
For the quantitative component, programmatic data on the tuberculosis and HIV strategies in the health facilities were inspected. Existing administrative and clinical registries for each health facility were consulted for 2010 to 2015. Additional information was requested from health workers to complement the foregoing. The data collection instrument was prepared by adapting the checklist from a similar project in Honduras (15) . It . Before collecting information, the objective and study procedures were presented to the chief or head of each health facility. Health workers from the facility's tuberculosis and HIV strategies were then invited to take part in the study. Patients were invited through the health workers. An informed consent form had to be read and signed to participate in the study.
RESULTS

Qualitative component
Twenty-two key actors (16 health providers, four patients, and two staff members) were interviewed. Several barriers to comprehensive care of patients with TB/HIV were identified.
The first barrier is little or no coordination of activities, such as HIV screening in tuberculosis patients or monitoring compliance with treatment. Health workers' experience and knowledge influence this relationship. Other factors are staff willingness and interest, physical proximity, and affinity among those responsible. Comprehensive care of TB/HIV coinfection requires the services aimed at managing those pathologies to maintain fluid communication, so that the status of each patient is known. The principal results of this lack of coordination are that there is no linkage between the services, for example, patients who received reagent screening in TB services but who do not go to the HIV services, or patients lost to follow-up, in the case of people with HIV who were diagnosed with TB but do not seek treatment.
In Peru, TB/HIV coinfection tends to be treated at different health facilities, hampering coordination between the teams. This is because the TB and HIV care models differ in several ways. For TB, patients are seen in primary care facilities, close to home, where they receive directly observed treatment (DOT). HIV, in turn, is managed in some secondaryor tertiary-level health facilities that have trained professionals, where drugs are delivered every month or two months, according to patient needs. Because of this fragmentation, health professionals do not know the patient's status, there is lack of adherence to treatment, and patients experience financial problems. The absence of an integrated information system hinders monitoring of coinfected patients and overall data analysis. Furthermore, cases are registered manually, so information can be lost. The absence of computer equipment and properly functioning Internet service contributes to this problem. This barrier is especially apparent at the central level, since when data are consolidated, they are found to be inconsistent. This, in turn, reflects the lack of coordination between the services and the fact that a single patient goes to different health facilities that use different IDs, which creates reporting duplications or omissions.
There are also barriers related to problems in the health system, such as insufficient funding for the strategies and lack of human resources. The workers interviewed agree that the real issue is not lack of money, but the quality of spending. The funds generally come from the results-based budget (RBB) and are not used for the tuberculosis and HIV strategies, since facility officials allocate these resources to other expenditures. In Peru, the shortage of health workers is due not only to a lack of professionals, but also to their uneven distribution. Health professionals therefore have to split their time between administrative tasks and patient care. In the case of the TB and HIV strategies, the workers are not only in charge of the day-to-day care of patients, but also of activity programming, management, and reporting. The issue is compounded by high staff turnover because of a lack of labor incentives, which has an impact on all the activities of both strategies. Personnel shortages are also related to insufficient funding, and the human resources lack regular and refresher training, particularly at the primary care level. 
"[ ... ] because the authorities use the budget for other things. It is a constant struggle to try to protect the funds we have; some support us, others don't; theirs is more of a welfare approach [ ... ]" (IQT_01_III)
Quantitative component
DISCUSSION
This study identified the programmatic barriers that hinder access to comprehensive care of patients with TB/ HIV coinfection in seven health facilities in Lima and Iquitos, Peru. These barriers include difficulties coordinating between the tuberculosis and HIV strategies, fragmentation of care in different health facilities, the absence of policy documents for managing this condition and the lack of an integrated information system. Other barriers are insufficient funding for their work, the scarcity of health workers and their lack of training. Some indicators, such as screening tuberculosis patients for HIV, have improved notably. However, isoniazid coverage in HIV patients is still well below the national target of 100%.
The most significant difference in the indicators evaluated in the Lima and Iquitos health facilities was IPT coverage. This could be due to current regulations not being implemented or weak supply of the drugs in the jungle region, among other possible reasons that could be explored further in another study.
Collaboration between tuberculosis and HIV programs has been analyzed in several studies, which found that lack of integration at the different levels is a problem common to several contexts (12, (16) (17) (18) (19) . Much like in our study, other HIV, human immunodeficiency virus; TB, tuberculosis. research has found that this lack of integration results in monitoring difficulty, loss of cases, fragmentation of care, and more missed opportunities (16, 19) . These barriers have also been found to have effects on indicators, such as IPT coverage in patients with HIV and high mortality in patients with coinfection, in addition to the lack of data for constructing indicators, such as ARVT coverage in patients with tuberculosis. Lack of financing and human resources are two more major barriers that tend to be present in the Peruvian health system (20, 21) . As in our study, they limit the integration of joint tuberculosis and HIV activities (22, 23) . Furthermore, lack of staff training is a key factor, since it would contribute to better management of TB/HIV coinfection, and of available mechanisms for streamlining the processes for patients. The technical document should provide a legal framework that prompts changes in administrative procedures and, in turn, facilitates human resources education and makes the health interventions sustainable.
This study did not examine barriers from the patient's standpoint. Other studies have found that personal factors, such as lifestyle, socioeconomic problems, social support, lack of understanding of the treatment, stigma and discrimination, and alcohol and drug use affect the treatment of TB/ HIV coinfection (24) (25) (26) (27) . Although these factors are important, they are difficult to solve from a programmatic standpoint, since they require a multisectoral approach. Furthermore, better health system performance (measured by the context, integration, support services, human resources and service continuity and quality) is found to be related to better treatment outcomes (cure or adherence to treatment) in patients with TB/HIV coinfection (28) . This study's principal limitation is possible social desirability bias, especially on the part of patients, since the interviews were conducted at the health facilities. There could also be participant selection bias, since those available at the time of the visit were the ones interviewed. However, the information obtained is consistent with the type of key actor interviewed, which gives us confidence that the barriers were adequately explored. The limitations of the quantitative component are related to the data source, since registries can underreport cases or activities. This bias is expected to be similar across the facilities and, therefore, does not affect comparisons. In spite of these constraints, this study contributes information that will enable decision-makers to identify weaknesses, from a system standpoint, in the care of TB/HIV coinfection.
Lastly, a barrier identified by this study is the lack of a technical document for TB/HIV coinfection care. Accordingly, during this research, a document was prepared standardizing comprehensive care processes for patients with TB/ HIV coinfection, addressing the main barriers encountered. Furthermore, a meeting was organized between the tuberculosis and HIV teams at the central level and in some health facilities in Lima to discuss some elements of the technical document. The next steps (validation and subsequent implementation) should, however, involve all the actors; otherwise, it would run the risk of being ignored at the operational level (29) .
CONCLUSIONS
There is poor coordination between HIV and TB health strategies in health facilities included in the study.
Management of TB/HIV coinfection is fragmented, which hinders comprehensive patient care. These findings point to the need for specific policies and regulations to address the problem of TB/HIV coinfection in Peru. As a result, a joint technical document on TB/HIV was prepared. It establishes health interventions and administrative procedures in health services at the national level and aims to reduce the incidence, morbidity, and mortality of people affected by TB and HIV in Peru.
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Barreras para el acceso a la atención integral de las personas afectadas por la coinfección por tuberculosis y virus de inmunodeficiencia humana en Perú, 2010-2015 Barreiras no acesso à atenção integral de pessoas afetadas pela coinfecção por tuberculose e vírus da imunodeficiência humana no Peru, 2010 a 2015 RESUMEN Objetivo. Identificar las barreras programáticas que dificultan el acceso a la atención inte gral de pacientes con coinfección por tuberculosis y virus de la inmunodeficiencia humana (TB/VIH). Métodos. Se trata de un estudio de métodos mixtos. La investigación cualitativa se realizó mediante entrevistas en profundidad a actores clave y el componente cuantitativo a través del análisis descriptivo de corte transversal de datos programáticos del período 2010-2015 sobre los programas de tuberculosis y VIH de establecimientos de salud de las ciudades de Lima e Iquitos.
Resultados. Se entrevistaron a 22 actores clave en siete establecimientos. Las barreras identi ficadas fueron: poca o ninguna coordinación entre los equipos de tuberculosis y VIH, manejo por separado de los casos de tuberculosis y de VIH en diferentes niveles de atención, financia miento insuficiente, recursos humanos escasos o poco capacitados y ausencia de un sistema de información integrado. Se evidenció que el tamizaje para VIH en pacientes con tuberculosis se incrementó (de 18,8% en 2011 a 95,2% en 2015), la cobertura de isoniazida en pacientes con VIH disminuyó (de 62% a 9%) y la proporción de fallecidos entre los casos de coinfección por TB/VIH fue de 20% en promedio. Conclusiones. Existe una débil coordinación entre las estrategias sanitarias sobre VIH y sobre tuberculosis. El manejo de la coinfección por TB/VIH es fragmentado en diferentes nive les de atención, lo que repercute en la atención integral del paciente. Como producto de esta investigación, se elaboró un documento técnico para establecer los procedimientos conjuntos, el cual deberá ser implementado para una mejora en la atención integral de la coinfección por TB/VIH.
